Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vascular Surgery
  Free Subscription

Articles published in
J Cardiol
    June 2024
  1. KOBAYASHI S, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Impact of controlled blood pressure and pulse rate at discharge on clinical outcomes in patients with ST-segment elevation myocardial infarction.
    J Cardiol. 2024;83:394-400.
    >> Share

    May 2024
  2. GIKANDI A, Habertheuer A, Stock EM, Hirji S, et al
    Anatomical SYNTAX score and major adverse cardiac events following CABG in the REGROUP trial.
    J Cardiol. 2024;83:348-350.
    >> Share

  3. SHOJI S, Kuno T, Ueyama H, Takagi H, et al
    Preferred monotherapy after short-term dual antiplatelet therapy: Systematic review and network meta-analysis of randomized trials.
    J Cardiol. 2024;83:338-347.
    >> Share

    April 2024
  4. BAVISHI C, Davies RE, Matsuno S, Kobayashi N, et al
    Practice differences and knowledge gaps in complex and high-risk interventions between Japan and the USA: A case-based discussion.
    J Cardiol. 2024;83:272-279.
    >> Share

    January 2024
  5. YOSHIZAKI T, Nakamura T, Horikoshi T, Watanabe Y, et al
    Impact of atherothrombotic risk stratification in patients with heavily calcified lesions following rotational atherectomy.
    J Cardiol. 2024;83:37-43.
    >> Share

  6. SERRIER H, Rabier H, Fernandez V, Schott AM, et al
    Comparison of healthcare costs before and after a STEMI: A French national health data system-based cohort study.
    J Cardiol. 2024;83:44-48.
    >> Share

    December 2023
  7. ISAWA T, Horie K, Toyoda S, Taguri M, et al
    Prognostic impact of Achilles tendon thickness in elderly patients after percutaneous coronary intervention: A 5-year follow-up.
    J Cardiol. 2023;82:448-454.
    >> Share

  8. SAYAMA K, Hoshino M, Kanaji Y, Sugiyama T, et al
    Prognostic implications of non-infarct-related territory unrecognized myocardial infarction in patients with non-ST-segment-elevation acute coronary syndrome.
    J Cardiol. 2023;82:433-440.
    >> Share

  9. SAKUMA Y, Shimizu T, Kurosawa Y, Ohara H, et al
    Impact of bleeding event for new cancer diagnosis in patients with antiplatelet therapy after percutaneous coronary intervention.
    J Cardiol. 2023;82:460-466.
    >> Share

    November 2023
  10. AKAO K, Onoda H, Imamura T
    Detailed association between dominant right coronary artery and acute occlusion of unprotected left main coronary artery.
    J Cardiol. 2023;82:429.
    >> Share

  11. FUJITO H, Fukamachi D, Ohgaku A, Kojima K, et al
    Hepatic steatosis evidenced by computed tomography in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    J Cardiol. 2023;82:414-422.
    >> Share

    September 2023
  12. OKABE H, Inoue K, Tanaka M, Kakumori D, et al
    Effects of contrast medium viscosity into flushing port on artefacts during optical coherence tomography imaging.
    J Cardiol. 2023;82:194-200.
    >> Share

  13. JONES D, Spirito A, Sartori S, Smith KF, et al
    Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.
    J Cardiol. 2023;82:179-185.
    >> Share

  14. IWAMA M, Noda T, Takagi K, Tanaka A, et al
    Impact of right coronary artery dominance on the long-term mortality in the patients with acute total/subtotal occlusion of unprotected left main coronary artery.
    J Cardiol. 2023;82:165-171.
    >> Share

    June 2023
  15. ITO R, Yamashita J, Ikeda S, Nakajima Y, et al
    Predictors of procedural complications in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    J Cardiol. 2023 Jun 26:S0914-5087(23)00156-9. doi: 10.1016/j.jjcc.2023.
    >> Share

  16. KITAHARA H, Yamashita D, Sato T, Suzuki S, et al
    Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention.
    J Cardiol. 2023 Jun 17:S0914-5087(23)00138-7. doi: 10.1016/j.jjcc.2023.
    >> Share

  17. IWATA J, Inohara T, Shiraishi Y, Nakamaru R, et al
    Standard modifiable cardiovascular risk factors in patients with acute coronary syndrome: A report from multicenter percutaneous coronary intervention registry.
    J Cardiol. 2023;81:571-576.
    >> Share

  18. NISHIO R, Ogita M, Suwa S, Nakao K, et al
    Shorter door-to-balloon time, better long-term clinical outcomes in ST-segment elevation myocardial infarction patients: J-MINUET substudy.
    J Cardiol. 2023;81:564-570.
    >> Share

  19. SHIMONO H, Tokushige A, Kanda D, Ohno A, et al
    Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.
    J Cardiol. 2023;81:553-563.
    >> Share

  20. YAMADA K, Ishikawa T, Nakamura H, Mizutani Y, et al
    Midterm safety and efficacy of elective drug-coated balloon angioplasty in comparison to drug-eluting stents for unrestrictive de novo coronary lesions: A single center retrospective study.
    J Cardiol. 2023;81:537-543.
    >> Share

    May 2023
  21. HAMEED I, Malik S, Nusrat K, Siddiqui OM, et al
    Effect of vitamin D on postoperative atrial fibrillation in patients who underwent coronary artery bypass grafting: A systematic review and Meta-analysis.
    J Cardiol. 2023 May 24:S0914-5087(23)00113-2. doi: 10.1016/j.jjcc.2023.
    >> Share

    April 2023
  22. SUZUKI T, Fujino M, Murai K, Iwai T, et al
    Urinary catheterization prior to PCI worsens clinical outcomes in patients with acute myocardial infarction.
    J Cardiol. 2023;81:373-377.
    >> Share

  23. UEKI Y, Kuwahara K
    Periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    J Cardiol. 2023;81:364-372.
    >> Share

  24. TAKURA T, Komuro I, Ono M
    Trends in the cost-effectiveness level of percutaneous coronary intervention: Macro socioeconomic analysis and health technology assessment.
    J Cardiol. 2023;81:356-363.
    >> Share

    March 2023
  25. CHOW JK, Bagai A, Tan MK, Har BJ, et al
    Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF+PCI-II Program.
    J Cardiol. 2023 Mar 15:S0914-5087(23)00052-7. doi: 10.1016/j.jjcc.2023.
    >> Share

    February 2023
  26. MORI H, Sakurai K, Ikari Y, Fukui K, et al
    Radial versus femoral access in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A propensity-matched analysis from real-world data of the K-ACTIVE registry.
    J Cardiol. 2023;81:189-195.
    >> Share

  27. KAWAMURA K, Ejiri K, Toda H, Yamanaka T, et al
    Association between home-based exercise using a pedometer and clinical prognosis after endovascular treatment in patients with peripheral artery disease.
    J Cardiol. 2023;81:222-228.
    >> Share

  28. SEGUCHI M, Aytekin A, Lenz T, Nicol P, et al
    Challenges of the newer generation of resorbable magnesium scaffolds: Lessons from failure mechanisms of the past generation.
    J Cardiol. 2023;81:179-188.
    >> Share

  29. SAITO Y, Oyama K, Tsujita K, Yasuda S, et al
    Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond.
    J Cardiol. 2023;81:168-178.
    >> Share

    January 2023
  30. FUKUIZUMI I, Tokita Y, Shiomura R, Noma S, et al
    Angioscopic findings 1 year after percutaneous coronary intervention for chronic total occlusion.
    J Cardiol. 2023;81:91-96.
    >> Share

  31. SAKAGAMI A, Soeda T, Saito Y, Nakao K, et al
    Clinical impact of beta-blockers at discharge on long-term clinical outcomes in patients with non-reduced ejection fraction after acute myocardial infarction.
    J Cardiol. 2023;81:83-90.
    >> Share

    December 2022
  32. ISHIHARA T, Iida O, Takahara M, Tsujimura T, et al
    Clinical course of patients with chronic limb-threatening ischemia developing COVID-19.
    J Cardiol. 2022;80:545-548.
    >> Share

  33. KIRIGAYA H, Okada K, Hibi K, Maejima N, et al
    Post-procedural quantitative flow ratio gradient and target lesion revascularization after drug-coated balloon or plain-old balloon angioplasty.
    J Cardiol. 2022;80:511-517.
    >> Share

  34. YAMAMOTO MH, Kondo S, Mizukami T, Yasuhara S, et al
    Rationale and design of the TACTICS registry: Optical coherence tomography guided primary percutaneous coronary intervention for patients with acute coronary syndrome.
    J Cardiol. 2022;80:505-510.
    >> Share

  35. MIZUNO Y, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Impact of rotational atherectomy on the incidence of side branch compromise in calcified bifurcation lesions undergoing elective percutaneous coronary intervention.
    J Cardiol. 2022;80:518-524.
    >> Share

  36. JAFFAR-KARBALLAI M, Haque A, Voller C, Elleithy A, et al
    Clinical and technical outcomes of robotic versus manual percutaneous coronary intervention: A systematic review and meta-analysis.
    J Cardiol. 2022;80:495-504.
    >> Share

    November 2022
  37. NAKAO M, Inagaki Y, Hata T, Morioka Y, et al
    Clinical outcomes of endovascular therapy with vascular stents for central venous obstruction in hemodialysis patients.
    J Cardiol. 2022;80:469-474.
    >> Share

  38. TROGER F, Reindl M, Tiller C, Lechner I, et al
    Prevalence and prognostic impact of mitral annular disjunction in patients with STEMI - A cardiac magnetic resonance study.
    J Cardiol. 2022;80:397-401.
    >> Share

  39. OTA S, Nishiguchi T, Taruya A, Tanimoto T, et al
    Hyperglycemia and intramyocardial hemorrhage in patients with ST-segment elevation myocardial infarction.
    J Cardiol. 2022;80:456-461.
    >> Share

    October 2022
  40. TOSHIMA T, Watanabe T, Goto J, Kobayashi Y, et al
    Impact of activities of daily living on percutaneous coronary intervention and acute and long-term mortality in patients with acute myocardial infarction: Yamagata AMI registry.
    J Cardiol. 2022;80:313-318.
    >> Share

    September 2022
  41. SEKI T, Takeuchi M, Kawakami K
    Comparison of noninvasive follow-up testing in patients after percutaneous coronary intervention with drug-eluting stent implantation.
    J Cardiol. 2022;80:275-282.
    >> Share

  42. NAKAHASHI T, Sakata K, Masuda J, Kumagai N, et al
    Impact of hyperuricemia on coronary blood flow and in-hospital mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    J Cardiol. 2022;80:268-274.
    >> Share

    August 2022
  43. KIMURA T, Akahori H, Tanaka T, Yanaka K, et al
    Impact of lipoprotein (a) on long-term outcome after percutaneous coronary intervention in the era of new generation drug-eluting stents.
    J Cardiol. 2022;80:179-183.
    >> Share

  44. SHIMA Y, Kubo S, Ikuta A, Ohya M, et al
    Feasibility and safety of coronary catheterization with the distal radial approach for hemodialysis patients.
    J Cardiol. 2022;80:162-166.
    >> Share

  45. MATSUMOTO I, Moriya S, Kurozumi M, Namba T, et al
    Simultaneous evaluation of fatty acid and triglycerides after percutaneous coronary intervention.
    J Cardiol. 2022;80:149-154.
    >> Share

  46. TAKAHASHI K, Miura K, Shima Y, Okabe K, et al
    Comparison of original and modified Academic Research Consortium for High Bleeding Risk definitions in real-world practice.
    J Cardiol. 2022;80:155-161.
    >> Share

    July 2022
  47. YAMAJI K, Iwanaga Y, Kawamura T, Fujita K, et al
    Plaque characteristics and prognosis in patients with peripheral arterial disease by angioscopic analysis.
    J Cardiol. 2022;80:94-100.
    >> Share

    June 2022
  48. SATO T, Saito Y, Matsumoto T, Yamashita D, et al
    In-hospital adverse events in low-risk patients with acute myocardial infarction - Potential implications for earlier discharge.
    J Cardiol. 2022;79:747-751.
    >> Share

    May 2022
  49. ZHANG S, Ji MH, Ding S, Wu Y, et al
    Inclusion of interleukin-6 improved performance of postoperative delirium prediction for patients undergoing coronary artery bypass graft (POD-CABG): A derivation and validation study.
    J Cardiol. 2022;79:634-641.
    >> Share

  50. HROMADKA M, Motovska Z, Hlinomaz O, Kala P, et al
    The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI: Observations from Prague-18 Study.
    J Cardiol. 2022;79:626-633.
    >> Share

  51. HE HM, He C, Zhang SC, You ZB, et al
    Predictive value of aspartate aminotransferase-to-alanine aminotransferase ratio for contrast-associated acute kidney injury in patients undergoing elective percutaneous coronary intervention.
    J Cardiol. 2022;79:618-625.
    >> Share

    April 2022
  52. YAMAJI K, Mitsutake Y, Nakano M, Nakamura T, et al
    Robotic-assisted percutaneous coronary intervention in the COVID-19 pandemic.
    J Cardiol. 2022;79:455-459.
    >> Share

  53. KITAHARA H, Yamazaki T, Hiraga T, Yamashita D, et al
    Extent of lipid core plaque in patients with Achilles tendon xanthoma undergoing percutaneous coronary intervention for coronary artery disease.
    J Cardiol. 2022;79:559-563.
    >> Share

  54. RUSSO JJ, Yan AT, Pocock SJ, Brieger D, et al
    Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry.
    J Cardiol. 2022;79:522-529.
    >> Share

  55. SHIYOVICH A, Ovdat T, Klempfner R, Beigel R, et al
    Worse outcomes of ACS patients without versus with traditional cardiovascular risk factors.
    J Cardiol. 2022;79:515-521.
    >> Share

  56. NISHIO R, Dohi T, Takeuchi M, Takahashi N, et al
    Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
    J Cardiol. 2022;79:509-514.
    >> Share

    March 2022
  57. SHOJI K, Yanishi K, Kawamata H, Hori Y, et al
    New risk factors for early- and late-onset cardiac rupture in ST-elevation myocardial infarction patients after primary percutaneous coronary intervention.
    J Cardiol. 2022;79:400-407.
    >> Share

    February 2022
  58. MURAKAMI T, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Complications related to veno-arterial extracorporeal membrane oxygenation in patients with acute myocardial infarction: VA-ECMO complications in AMI.
    J Cardiol. 2022;79:170-178.
    >> Share

  59. MIR T, Uddin M, Shah A, Khan MZ, et al
    ST elevation myocardial infarction and kidney transplant: A large cohort study: STEMI and renal transplant.
    J Cardiol. 2022;79:270-276.
    >> Share

  60. HE HM, Zhang SC, He C, You ZB, et al
    Association between neutrophil percentage-to-albumin ratio and contrast-associated acute kidney injury in patients without chronic kidney disease undergoing percutaneous coronary intervention.
    J Cardiol. 2022;79:257-264.
    >> Share

    January 2022
  61. IMAMURA T
    Implication of early cardiac rehabilitation following acute myocardial infarction.
    J Cardiol. 2022;79:161-162.
    >> Share

  62. KOJIMA K, Komatsu S, Kakuta T, Fukamachi D, et al
    Aortic plaque burden predicts vascular events in patients with cardiovascular disease: The EAST-NOGA study.
    J Cardiol. 2022;79:144-152.
    >> Share

  63. ASAKURA M, Hibi K, Shimizu W, Fujii K, et al
    Design and rationale of the EVOCATION trial: A prospective, randomized, exploratory study comparing the effect of evolocumab on coronary microvascular function after percutaneous coronary intervention in patients with stable coronary artery disease.
    J Cardiol. 2022;79:105-109.
    >> Share

  64. MIR T, Qureshi WT, Uddin M, Shafi O, et al
    Non-ST elevation myocardial infarction and cardiac arrest: The United States Nationwide Emergency Department Sample.
    J Cardiol. 2022;79:98-104.
    >> Share

  65. TAKAHARA M, Iida O, Soga Y, Kodama A, et al
    Features of asymptomatic contralateral limb in patients with chronic limb-threatening ischemia.
    J Cardiol. 2022;79:153-160.
    >> Share

  66. TAKAHASHI T, Theodoropoulos K, Latib A, Okura H, et al
    Coronary physiologic assessment based on angiography and intracoronary imaging.
    J Cardiol. 2022;79:71-78.
    >> Share

    December 2021
  67. TAKEUCHI D, Uto K, Inai K, Nagashima Y, et al
    Prominent atrial fibrosis and its correlation with dilated atrium atrial tachyarrhythmia and long after classic Fontan surgery.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00360.
    >> Share

  68. MATSUMOTO I, Moriya S, Kurozumi M, Namba T, et al
    Relationship between serum uric acid levels and the incidence of cardiovascular events after percutaneous coronary intervention.
    J Cardiol. 2021;78:550-557.
    >> Share

  69. LEE HF, Cheng YW, Peng JR, Hsu CY, et al
    Impact of chronic kidney disease on long-term outcomes for coronary in-stent restenosis after drug-coated balloon angioplasty.
    J Cardiol. 2021;78:564-570.
    >> Share

  70. AKASHI R, Koga S, Yonekura T, Ikeda S, et al
    Cardio-ankle vascular index is associated with coronary plaque composition assessed with iMAP-intravascular ultrasound in patients with coronary artery disease.
    J Cardiol. 2021;78:502-508.
    >> Share

    November 2021
  71. SETOYAMA K, Sonoda S, Naka Y, Okabe H, et al
    Right ventricular branch compromise after percutaneous coronary intervention and baseline chronic kidney disease: A high-risk combination associated with long-term prognoses in acute inferior myocardial infarction.
    J Cardiol. 2021;78:463-470.
    >> Share

  72. KODAIRA M, Sawano M, Tanaka M, Kuno T, et al
    Female sex as an independent predictor of high bleeding risk among East Asian percutaneous coronary intervention patients: A sex difference analysis.
    J Cardiol. 2021;78:431-438.
    >> Share

  73. BICCIRE FG, Pastori D, Torromeo C, Acconcia MC, et al
    Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes.
    J Cardiol. 2021;78:368-374.
    >> Share

    October 2021
  74. HATA Y, Iida O, Takahara M, Asai M, et al
    Saphenous vein size as a surrogate marker for mortality of patients with chronic limb-threatening ischemia undergoing endovascular therapy.
    J Cardiol. 2021;78:341-346.
    >> Share

    September 2021
  75. SHIGETOSHI M, Hatanaka K, Ogawa A, Tabuchi I, et al
    Oxygen inhalation can selectively dilate pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension before balloon angioplasty.
    J Cardiol. 2021 Sep 22. pii: S0914-5087(21)00236.
    >> Share

  76. SATO T, Saito Y, Matsumoto T, Yamashita D, et al
    Impact of CADILLAC and GRACE risk scores on short- and long-term clinical outcomes in patients with acute myocardial infarction.
    J Cardiol. 2021;78:201-205.
    >> Share

  77. NISHI T, Okada K, Kitahara H, Kameda R, et al
    Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials.
    J Cardiol. 2021;78:224-229.
    >> Share

  78. KATO A, Sato J, Yoshii K, Yoshida S, et al
    The mid-term outcome of Fontan conversion compared with primary total cavopulmonary connection.
    J Cardiol. 2021;78:213-218.
    >> Share

    August 2021
  79. HIOKI H, Kozuma K, Kinoshita Y, Nanasato M, et al
    Ischemic/bleeding event after short dual-antiplatelet therapy in patients with high bleeding risk: Sub-analysis of the MODEL U-SES study.
    J Cardiol. 2021;78:107-113.
    >> Share

  80. HONDA S, Nishihira K, Kojima S, Takegami M, et al
    Characteristics and clinical outcomes of patients with de-escalation from prasugrel to clopidogrel after acute myocardial infarction - Insights from the prospective Japan Acute Myocardial Infarction Registry (JAMIR).
    J Cardiol. 2021;78:99-106.
    >> Share

  81. NAKAMURA M, Iijima R
    Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention: Start with what is right rather than what is acceptable.
    J Cardiol. 2021;78:91-98.
    >> Share

    July 2021
  82. SUMINO Y, Yonetsu T, Ueno H, Nogami K, et al
    Clinical significance of neoatherosclerosis observed at very late phase between 3 and 7 years after coronary stent implantation.
    J Cardiol. 2021;78:58-65.
    >> Share

    June 2021
  83. WONGSALAP Y, Kengkla K, Poolpun D, Saokaew S, et al
    Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand.
    J Cardiol. 2021;77:669-676.
    >> Share

  84. MATSUDA J, Hamaya R, Hoshino M, Kanaji Y, et al
    FFR=1.0 flow changes after percutaneous coronary intervention.
    J Cardiol. 2021;77:634-640.
    >> Share

  85. KOGA S, Ikeda S, Akashi R, Yonekura T, et al
    Serum soluble Klotho is inversely related to coronary artery calcification assessed by intravascular ultrasound in patients with stable coronary artery disease.
    J Cardiol. 2021;77:583-589.
    >> Share

  86. TIEN YY, Huang HK, Shih MC, Tu YK, et al
    Drug repurposing? Cardiovascular effect of colchicine on patients with coronary artery disease: A systematic review and meta-analysis.
    J Cardiol. 2021;77:576-582.
    >> Share

  87. TOSHIMA T, Hirayama A, Watanabe T, Goto J, et al
    Unmet needs for emergency care and prevention of prehospital death in acute myocardial infarction.
    J Cardiol. 2021;77:605-612.
    >> Share

    May 2021
  88. HOKAMA Y, Tanaka N, Takashima H, Kadota K, et al
    Insufficient recovery of fractional flow reserve even after optimal implantation of drug-eluting stents: 3-year outcomes from the FUJI study.
    J Cardiol. 2021;77:532-538.
    >> Share

  89. UCHIDA Y, Shimoyama E, Hiruta N, Tabata T, et al
    Detection of early stage of human coronary atherosclerosis by angioscopic imaging of collagen subtypes.
    J Cardiol. 2021;77:452-456.
    >> Share

  90. TERASHIMA M, Kaneda H, Honda Y, Shimura T, et al
    Current status of hybrid intravascular ultrasound and optical coherence tomography catheter for coronary imaging and percutaneous coronary intervention.
    J Cardiol. 2021;77:435-443.
    >> Share

  91. TSUJIMURA T, Ishihara T, Okuno S, Iida O, et al
    Angioscopic assessments and clinical outcomes one year after polymer-free biolimus A9-coated coronary stent implantation.
    J Cardiol. 2021;77:457-464.
    >> Share

    April 2021
  92. FUKASE T, Dohi T, Kato Y, Chikata Y, et al
    Long-term clinical outcomes and cause of death after endovascular treatment for femoropopliteal artery lesions.
    J Cardiol. 2021;77:417-423.
    >> Share

  93. WATANABE S, Usui M
    Clinical features of ST-segment elevation myocardial infarction in patients receiving welfare public assistance in urban area of Japan.
    J Cardiol. 2021;77:404-407.
    >> Share

  94. ASHER E, Abu-Much A, Bragazzi NL, Younis A, et al
    CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.
    J Cardiol. 2021;77:375-379.
    >> Share

    March 2021
  95. HAGIWARA H, Fukuta H, Hashimoto H, Niimura T, et al
    A comparison of the safety and effectiveness of prasugrel and clopidogrel in younger population undergoing percutaneous coronary intervention: A retrospective study using a Japanese claims database.
    J Cardiol. 2021;77:285-291.
    >> Share

  96. TOMITA H, Fujii T, Kise H, Oyama N, et al
    Percutaneous pulmonary artery debanding.
    J Cardiol. 2021;77:307-312.
    >> Share

  97. NUIS RJ, Jadoon A, van Dalen BM, Dulfer K, et al
    Patient perspectives on left main stem revascularization strategies, the OPINION-2 study.
    J Cardiol. 2021;77:271-278.
    >> Share

    February 2021
  98. ZHANG G, Zhao Z, Han Z, Gao Q, et al
    The predictive value of intraoperative transit-time flow measurement parameters for early graft failure in different target territories.
    J Cardiol. 2021;77:201-205.
    >> Share

  99. MITARAI T, Tanabe Y, Akashi YJ, Maeda A, et al
    A novel risk stratification system "Angiographic GRACE Score" for predicting in-hospital mortality of patients with acute myocardial infarction: Data from the K-ACTIVE Registry.
    J Cardiol. 2021;77:179-185.
    >> Share

  100. YAMAGUCHI T, Ueshima D, Utsunomiya M, Matsui A, et al
    Optimal cut-off value of preprocedural geriatric nutritional risk index for predicting the clinical outcomes of patients undergoing endovascular revascularization for peripheral artery disease.
    J Cardiol. 2021;77:109-115.
    >> Share

  101. YOSHIOKA N, Takagi K, Morishima I, Morita Y, et al
    Association between discharge destination and mid-term mortality in octogenarian patients with ST-elevation myocardial infarction.
    J Cardiol. 2021;77:116-123.
    >> Share

    January 2021
  102. NISHI H, Kodama K
    Author's reply: Can non-obstructive general angioscopy predict and aortic dissection before an attack?
    J Cardiol. 2021;77:106-108.
    >> Share

  103. KOJIMA K, Fukamachi D, Okumura Y
    Can non-obstructive general angioscopy predict an aortic dissection before an attack?
    J Cardiol. 2021;77:106-108.
    >> Share

  104. SHIINA Y, Nagao M, Shimomiya Y, Inai K, et al
    Secondary sarcopenia assessed by computed tomography can predict hospitalization for heart failure in adults with Fontan circulation.
    J Cardiol. 2021;77:10-16.
    >> Share

    September 2020
  105. NAKAMURA M, Yamashita T, Hayakawa A, Matsumoto T, et al
    Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: A comparative study.
    J Cardiol. 2020 Sep 14. pii: S0914-5087(20)30293.
    >> Share

  106. KIMURA M, Kohno T, Sawano M, Heidenreich PA, et al
    Independent and cumulative association of clinical and morphological heart failure with long-term outcome after percutaneous coronary intervention.
    J Cardiol. 2020 Sep 1. pii: S0914-5087(20)30208.
    >> Share

    August 2020
  107. MEHRAN R, Vogel B, Levy P
    Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting.
    J Cardiol. 2020 Aug 26. pii: S0914-5087(20)30258.
    >> Share

    May 2020
  108. MINATSUKI S, Kodera S, Kiyosue A, Saito A, et al
    Balloon pulmonary angioplasty improves quality of life in Japanese patients with chronic thromboembolic pulmonary hypertension.
    J Cardiol. 2020 May 8. pii: S0914-5087(20)30071.
    >> Share

  109. AHN JH, Ahn Y, Jeong MH, Kim JH, et al
    Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health.
    J Cardiol. 2020;75:478-484.
    >> Share

  110. SATO K, Takahashi J, Hao K, Miyata S, et al
    Temporal trends in the prevalence and outcomes of geriatric patients with acute myocardial infarction in Japan-A report from the Miyagi AMI Registry Study.
    J Cardiol. 2020;75:465-472.
    >> Share

  111. HIGASHIOKA D, Shiono Y, Kubo T, Kitabata H, et al
    The inter-study reproducibility of instantaneous wave-free ratio and angiography coregistration.
    J Cardiol. 2020;75:507-512.
    >> Share

    November 2019
  112. ABE M, Masunaga N, Ishii M, Doi K, et al
    Current status of percutaneous coronary intervention in patients with atrial fibrillation: The Fushimi AF Registry.
    J Cardiol. 2019 Nov 3. pii: S0914-5087(19)30313.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016